Financhill
Sell
46

TFX Quote, Financials, Valuation and Earnings

Last price:
$113.66
Seasonality move :
1.38%
Day range:
$112.32 - $114.63
52-week range:
$112.32 - $249.91
Dividend yield:
1.2%
P/E ratio:
35.75x
P/S ratio:
1.76x
P/B ratio:
1.22x
Volume:
684K
Avg. volume:
531K
1-year change:
-50.58%
Market cap:
$5B
Revenue:
$3B
EPS (TTM):
$3.17

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
TFX
Teleflex
$771.5M $3.37 3.46% 42.49% $151.02
BSX
Boston Scientific
$4.9B $0.73 18.78% 229.3% $117.36
IART
Integra Lifesciences Holdings
$395.1M $0.43 -5.53% 241.78% $16.13
ISRG
Intuitive Surgical
$2.4B $1.92 17.01% 25.71% $581.45
LMAT
LeMaitre Vascular
$62.5M $0.57 11.88% 8.76% $104.50
PODD
Insulet
$612.3M $0.92 25.31% -64.13% $336.85
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
TFX
Teleflex
$113.32 $151.02 $5B 35.75x $0.34 1.2% 1.76x
BSX
Boston Scientific
$103.19 $117.36 $152.7B 75.32x $0.00 0% 8.75x
IART
Integra Lifesciences Holdings
$12.10 $16.13 $940.3M 70.14x $0.00 0% 0.57x
ISRG
Intuitive Surgical
$512.64 $581.45 $183.7B 75.17x $0.00 0% 21.35x
LMAT
LeMaitre Vascular
$82.61 $104.50 $1.9B 41.72x $0.20 0.87% 8.34x
PODD
Insulet
$288.27 $336.85 $20.3B 51.85x $0.00 0% 9.70x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
TFX
Teleflex
31.78% 0.276 30.89% 1.11x
BSX
Boston Scientific
33.49% 0.780 7.48% 0.68x
IART
Integra Lifesciences Holdings
54.74% 1.016 107.86% 0.57x
ISRG
Intuitive Surgical
-- 1.305 -- 3.81x
LMAT
LeMaitre Vascular
32.58% 1.324 8.86% 13.65x
PODD
Insulet
56.03% 1.967 9.18% 3.24x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
TFX
Teleflex
$389.4M $130.3M 2.43% 3.41% 18.2% $43.1M
BSX
Boston Scientific
$3.2B $937M 6.35% 9.57% 19.02% $277M
IART
Integra Lifesciences Holdings
$194.4M -$15.5M -0.86% -1.88% -2.93% -$40.2M
ISRG
Intuitive Surgical
$1.5B $578.1M 15.82% 15.82% 25.66% $465M
LMAT
LeMaitre Vascular
$41.4M $12.6M 11.41% 13.74% 25.94% $7.7M
PODD
Insulet
$409M $88.8M 15.79% 36.9% 10.07% $48.1M

Teleflex vs. Competitors

  • Which has Higher Returns TFX or BSX?

    Boston Scientific has a net margin of 13.56% compared to Teleflex's net margin of 14.45%. Teleflex's return on equity of 3.41% beat Boston Scientific's return on equity of 9.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    TFX
    Teleflex
    55.58% $2.07 $6B
    BSX
    Boston Scientific
    68.84% $0.45 $33.6B
  • What do Analysts Say About TFX or BSX?

    Teleflex has a consensus price target of $151.02, signalling upside risk potential of 33.27%. On the other hand Boston Scientific has an analysts' consensus of $117.36 which suggests that it could grow by 13.74%. Given that Teleflex has higher upside potential than Boston Scientific, analysts believe Teleflex is more attractive than Boston Scientific.

    Company Buy Ratings Hold Ratings Sell Ratings
    TFX
    Teleflex
    1 11 0
    BSX
    Boston Scientific
    23 2 0
  • Is TFX or BSX More Risky?

    Teleflex has a beta of 1.080, which suggesting that the stock is 8.03% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.679, suggesting its less volatile than the S&P 500 by 32.134%.

  • Which is a Better Dividend Stock TFX or BSX?

    Teleflex has a quarterly dividend of $0.34 per share corresponding to a yield of 1.2%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Teleflex pays 91.2% of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TFX or BSX?

    Teleflex quarterly revenues are $700.7M, which are smaller than Boston Scientific quarterly revenues of $4.7B. Teleflex's net income of $95M is lower than Boston Scientific's net income of $674M. Notably, Teleflex's price-to-earnings ratio is 35.75x while Boston Scientific's PE ratio is 75.32x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex is 1.76x versus 8.75x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TFX
    Teleflex
    1.76x 35.75x $700.7M $95M
    BSX
    Boston Scientific
    8.75x 75.32x $4.7B $674M
  • Which has Higher Returns TFX or IART?

    Integra Lifesciences Holdings has a net margin of 13.56% compared to Teleflex's net margin of -6.61%. Teleflex's return on equity of 3.41% beat Integra Lifesciences Holdings's return on equity of -1.88%.

    Company Gross Margin Earnings Per Share Invested Capital
    TFX
    Teleflex
    55.58% $2.07 $6B
    IART
    Integra Lifesciences Holdings
    50.81% -$0.33 $3.4B
  • What do Analysts Say About TFX or IART?

    Teleflex has a consensus price target of $151.02, signalling upside risk potential of 33.27%. On the other hand Integra Lifesciences Holdings has an analysts' consensus of $16.13 which suggests that it could grow by 33.27%. Given that Teleflex has higher upside potential than Integra Lifesciences Holdings, analysts believe Teleflex is more attractive than Integra Lifesciences Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    TFX
    Teleflex
    1 11 0
    IART
    Integra Lifesciences Holdings
    2 5 2
  • Is TFX or IART More Risky?

    Teleflex has a beta of 1.080, which suggesting that the stock is 8.03% more volatile than S&P 500. In comparison Integra Lifesciences Holdings has a beta of 1.152, suggesting its more volatile than the S&P 500 by 15.175%.

  • Which is a Better Dividend Stock TFX or IART?

    Teleflex has a quarterly dividend of $0.34 per share corresponding to a yield of 1.2%. Integra Lifesciences Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Teleflex pays 91.2% of its earnings as a dividend. Integra Lifesciences Holdings pays out -- of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TFX or IART?

    Teleflex quarterly revenues are $700.7M, which are larger than Integra Lifesciences Holdings quarterly revenues of $382.7M. Teleflex's net income of $95M is higher than Integra Lifesciences Holdings's net income of -$25.3M. Notably, Teleflex's price-to-earnings ratio is 35.75x while Integra Lifesciences Holdings's PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex is 1.76x versus 0.57x for Integra Lifesciences Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TFX
    Teleflex
    1.76x 35.75x $700.7M $95M
    IART
    Integra Lifesciences Holdings
    0.57x 70.14x $382.7M -$25.3M
  • Which has Higher Returns TFX or ISRG?

    Intuitive Surgical has a net margin of 13.56% compared to Teleflex's net margin of 30.99%. Teleflex's return on equity of 3.41% beat Intuitive Surgical's return on equity of 15.82%.

    Company Gross Margin Earnings Per Share Invested Capital
    TFX
    Teleflex
    55.58% $2.07 $6B
    ISRG
    Intuitive Surgical
    64.69% $1.92 $17.2B
  • What do Analysts Say About TFX or ISRG?

    Teleflex has a consensus price target of $151.02, signalling upside risk potential of 33.27%. On the other hand Intuitive Surgical has an analysts' consensus of $581.45 which suggests that it could grow by 13.42%. Given that Teleflex has higher upside potential than Intuitive Surgical, analysts believe Teleflex is more attractive than Intuitive Surgical.

    Company Buy Ratings Hold Ratings Sell Ratings
    TFX
    Teleflex
    1 11 0
    ISRG
    Intuitive Surgical
    14 9 1
  • Is TFX or ISRG More Risky?

    Teleflex has a beta of 1.080, which suggesting that the stock is 8.03% more volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.642, suggesting its more volatile than the S&P 500 by 64.249%.

  • Which is a Better Dividend Stock TFX or ISRG?

    Teleflex has a quarterly dividend of $0.34 per share corresponding to a yield of 1.2%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Teleflex pays 91.2% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TFX or ISRG?

    Teleflex quarterly revenues are $700.7M, which are smaller than Intuitive Surgical quarterly revenues of $2.3B. Teleflex's net income of $95M is lower than Intuitive Surgical's net income of $698.4M. Notably, Teleflex's price-to-earnings ratio is 35.75x while Intuitive Surgical's PE ratio is 75.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex is 1.76x versus 21.35x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TFX
    Teleflex
    1.76x 35.75x $700.7M $95M
    ISRG
    Intuitive Surgical
    21.35x 75.17x $2.3B $698.4M
  • Which has Higher Returns TFX or LMAT?

    LeMaitre Vascular has a net margin of 13.56% compared to Teleflex's net margin of 18.39%. Teleflex's return on equity of 3.41% beat LeMaitre Vascular's return on equity of 13.74%.

    Company Gross Margin Earnings Per Share Invested Capital
    TFX
    Teleflex
    55.58% $2.07 $6B
    LMAT
    LeMaitre Vascular
    69.18% $0.48 $515.6M
  • What do Analysts Say About TFX or LMAT?

    Teleflex has a consensus price target of $151.02, signalling upside risk potential of 33.27%. On the other hand LeMaitre Vascular has an analysts' consensus of $104.50 which suggests that it could grow by 26.5%. Given that Teleflex has higher upside potential than LeMaitre Vascular, analysts believe Teleflex is more attractive than LeMaitre Vascular.

    Company Buy Ratings Hold Ratings Sell Ratings
    TFX
    Teleflex
    1 11 0
    LMAT
    LeMaitre Vascular
    3 6 0
  • Is TFX or LMAT More Risky?

    Teleflex has a beta of 1.080, which suggesting that the stock is 8.03% more volatile than S&P 500. In comparison LeMaitre Vascular has a beta of 0.816, suggesting its less volatile than the S&P 500 by 18.388%.

  • Which is a Better Dividend Stock TFX or LMAT?

    Teleflex has a quarterly dividend of $0.34 per share corresponding to a yield of 1.2%. LeMaitre Vascular offers a yield of 0.87% to investors and pays a quarterly dividend of $0.20 per share. Teleflex pays 91.2% of its earnings as a dividend. LeMaitre Vascular pays out 32.65% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TFX or LMAT?

    Teleflex quarterly revenues are $700.7M, which are larger than LeMaitre Vascular quarterly revenues of $59.9M. Teleflex's net income of $95M is higher than LeMaitre Vascular's net income of $11M. Notably, Teleflex's price-to-earnings ratio is 35.75x while LeMaitre Vascular's PE ratio is 41.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex is 1.76x versus 8.34x for LeMaitre Vascular. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TFX
    Teleflex
    1.76x 35.75x $700.7M $95M
    LMAT
    LeMaitre Vascular
    8.34x 41.72x $59.9M $11M
  • Which has Higher Returns TFX or PODD?

    Insulet has a net margin of 13.56% compared to Teleflex's net margin of 6.22%. Teleflex's return on equity of 3.41% beat Insulet's return on equity of 36.9%.

    Company Gross Margin Earnings Per Share Invested Capital
    TFX
    Teleflex
    55.58% $2.07 $6B
    PODD
    Insulet
    71.88% $0.50 $3B
  • What do Analysts Say About TFX or PODD?

    Teleflex has a consensus price target of $151.02, signalling upside risk potential of 33.27%. On the other hand Insulet has an analysts' consensus of $336.85 which suggests that it could grow by 16.85%. Given that Teleflex has higher upside potential than Insulet, analysts believe Teleflex is more attractive than Insulet.

    Company Buy Ratings Hold Ratings Sell Ratings
    TFX
    Teleflex
    1 11 0
    PODD
    Insulet
    15 3 0
  • Is TFX or PODD More Risky?

    Teleflex has a beta of 1.080, which suggesting that the stock is 8.03% more volatile than S&P 500. In comparison Insulet has a beta of 1.346, suggesting its more volatile than the S&P 500 by 34.619%.

  • Which is a Better Dividend Stock TFX or PODD?

    Teleflex has a quarterly dividend of $0.34 per share corresponding to a yield of 1.2%. Insulet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Teleflex pays 91.2% of its earnings as a dividend. Insulet pays out -- of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios TFX or PODD?

    Teleflex quarterly revenues are $700.7M, which are larger than Insulet quarterly revenues of $569M. Teleflex's net income of $95M is higher than Insulet's net income of $35.4M. Notably, Teleflex's price-to-earnings ratio is 35.75x while Insulet's PE ratio is 51.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Teleflex is 1.76x versus 9.70x for Insulet. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    TFX
    Teleflex
    1.76x 35.75x $700.7M $95M
    PODD
    Insulet
    9.70x 51.85x $569M $35.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
82
SBET alert for Jul 17

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy
89
EXOD alert for Jul 17

Exodus Movement [EXOD] is down 4.14% over the past day.

Buy
60
U alert for Jul 17

Unity Software [U] is up 7.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock